Eusondia Arnett

1.4k total citations
25 papers, 828 citations indexed

About

Eusondia Arnett is a scholar working on Infectious Diseases, Immunology and Molecular Biology. According to data from OpenAlex, Eusondia Arnett has authored 25 papers receiving a total of 828 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 10 papers in Immunology and 9 papers in Molecular Biology. Recurrent topics in Eusondia Arnett's work include Tuberculosis Research and Epidemiology (8 papers), Mycobacterium research and diagnosis (6 papers) and Listeria monocytogenes in Food Safety (3 papers). Eusondia Arnett is often cited by papers focused on Tuberculosis Research and Epidemiology (8 papers), Mycobacterium research and diagnosis (6 papers) and Listeria monocytogenes in Food Safety (3 papers). Eusondia Arnett collaborates with scholars based in United States, Australia and Germany. Eusondia Arnett's co-authors include Larry S. Schlesinger, Stéphanie Seveau, Stephen Vadia, Chrissy M. Leopold Wager, Rodney K. Tweten, Abul Azad, Evelyn Guirado, Murugesan V. S. Rajaram, Susanta Pahari and Javed N. Agrewala and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and The Journal of Infectious Diseases.

In The Last Decade

Eusondia Arnett

22 papers receiving 824 citations

Peers

Countries citing papers authored by Eusondia Arnett

Since Specialization

Citations

This map shows the geographic impact of Eusondia Arnett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eusondia Arnett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eusondia Arnett more than expected).

Fields of papers citing papers by Eusondia Arnett

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eusondia Arnett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eusondia Arnett. The network helps show where Eusondia Arnett may publish in the future.

Co-authorship network of co-authors of Eusondia Arnett

This figure shows the co-authorship network connecting the top 25 collaborators of Eusondia Arnett. A scholar is included among the top collaborators of Eusondia Arnett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eusondia Arnett. Eusondia Arnett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Human alveolar macrophage function is impaired in tuberculosis contacts with diabetes 2025 ·EBioMedicine ·Léanie Kleynhans, (unknown), (unknown), (unknown), Alana Keyser, Niels D. Prins, (unknown), (unknown), Virginie Rozot, Martin Kidd, (unknown), Hong Cai, Yufeng Wang, Adam D. Ewing, Stephanus T. Malherbe, Abul Azad, Eusondia Arnett, Blanca I. Restrepo, Larry S. Schlesinger, Katharina Ronacher	0
2	Cutting Edge: Cytosolic Receptor AIM2 Is Induced by Peroxisome Proliferator-activated Receptor γ following Mycobacterium tuberculosis Infection of Human Macrophages but Does Not Contribute to IL-1β Release 2024 ·The Journal of Immunology ·Eusondia Arnett, J. Wolff, Chrissy M. Leopold Wager, (unknown), (unknown), (unknown), Bin Ni, Larry S. Schlesinger	4
3	Efficacy and Possible Mechanism(s) of Action of Gallium Tetraphenylporphyrin Nanoparticles against HIV-TB Coinfection in an In Vitro Granuloma Structure Model 2024 ·ACS Infectious Diseases ·Seoung‐ryoung Choi, Smita Kulkarni, Eusondia Arnett, Larry S. Schlesinger, Bradley E. Britigan, Prabagaran Narayanasamy	1
4	Bronchoscopy Without Sedation in Healthy Volunteers 2024 ·SHILAP Revista de lepidopterología ·Dean L. Kellogg, Diego J. Maselli, Kevin C. Proud, Eusondia Arnett, Larry S. Schlesinger, Jay I. Peters	0
5	A new tractable method for generating human alveolar macrophage-like cells in vitro to study lung inflammatory processes and diseases 2023 ·mBio ·Susanta Pahari, Eusondia Arnett, (unknown), Abul Azad, (unknown), Chengjin Ye, (unknown), Hong Cai, Yufeng Wang, Zhao Lai, (unknown), (unknown), Diego J. Maselli, Jay I. Peters, Jordi B. Torrelles, Luis Martínez‐Sobrido, Larry S. Schlesinger	13
6	Activation of transcription factor CREB in human macrophages by Mycobacterium tuberculosis promotes bacterial survival, reduces NF-kB nuclear transit and limits phagolysosome fusion by reduced necroptotic signaling 2023 ·PLoS Pathogens ·Chrissy M. Leopold Wager, (unknown), (unknown), (unknown), Eusondia Arnett, Larry S. Schlesinger	20
7	Ebola Virus Uses Tunneling Nanotubes as an Alternate Route of Dissemination 2023 ·The Journal of Infectious Diseases ·(unknown), (unknown), Eusondia Arnett, (unknown), Luis Martínez‐Sobrido, Rossella Titone, Laura J. Sherwood, Andrew Hayhurst, Larry S. Schlesinger, Olena Shtanko	6
8	Combination of MCL-1 and BCL-2 inhibitors is a promising approach for a host-directed therapy for tuberculosis 2023 ·Biomedicine & Pharmacotherapy ·Eusondia Arnett, Susanta Pahari, Chrissy M. Leopold Wager, (unknown), (unknown), (unknown), (unknown), María Montoya, Joseph T. Opferman, Larry S. Schlesinger	10
9	Systems biology approaches to investigate the role of granulomas in TB-HIV coinfection 2022 ·Frontiers in Immunology ·(unknown), Eusondia Arnett, Larry S. Schlesinger, Elsje Pienaar	7
10	Macrophage nuclear receptors: Emerging key players in infectious diseases 2019 ·PLoS Pathogens ·Chrissy M. Leopold Wager, Eusondia Arnett, Larry S. Schlesinger	44
11	Mycobacterium tuberculosis and macrophage nuclear receptors: What we do and don't know 2019 ·Tuberculosis ·Chrissy M. Leopold Wager, Eusondia Arnett, Larry S. Schlesinger	13
12	Characterization of AIM2 expression in human macrophages during M. tuberculosis infection 2019 ·The Journal of Immunology ·(unknown), Eusondia Arnett, Larry S. Schlesinger	0
13	Induction of autophagy through CLEC4E in combination with TLR4: an innovative strategy to restrict the survival of Mycobacterium tuberculosis 2019 ·Autophagy ·Susanta Pahari, Shikha Negi, Mohammad Aqdas, Eusondia Arnett, Larry S. Schlesinger, Javed N. Agrewala	64
14	PPARγ is critical for Mycobacterium tuberculosis induction of Mcl-1 and limitation of human macrophage apoptosis 2018 ·PLoS Pathogens ·Eusondia Arnett, (unknown), (unknown), María Montoya, Michael Li, Ky V. Hoang, Andrew Hayhurst, Abul Azad, Larry S. Schlesinger	56
15	Deletion of PPARγ in lung macrophages provides an immunoprotective response against M. tuberculosis infection in mice 2018 ·Tuberculosis ·Evelyn Guirado, Murugesan V. S. Rajaram, Ajay Chawla, (unknown), Krista M. D. La Perle, Eusondia Arnett, Joanne Turner, Larry S. Schlesinger	36
16	Relative Roles of Listeriolysin O, InlA, and InlB in Listeria monocytogenes Uptake by Host Cells 2018 ·Infection and Immunity ·(unknown), Stephen Vadia, Eusondia Arnett, Yubo Tan, Xiaoli Zhang, (unknown), Mikhail A. Gavrilin, Stéphanie Seveau	50
17	M. tuberculosis-Initiated Human Mannose Receptor Signaling Regulates Macrophage Recognition and Vesicle Trafficking by FcRγ-Chain, Grb2, and SHP-1 2017 ·Cell Reports ·Murugesan V. S. Rajaram, Eusondia Arnett, Abul Azad, Evelyn Guirado, Bin Ni, (unknown), Li-Zhen He, Tibor Keler, Lawrence J. Thomas, William P. Lafuse, Larry S. Schlesinger	100
18	Human isotype‐dependent inhibitory antibody responses against Mycobacterium tuberculosis 2016 ·EMBO Molecular Medicine ·(unknown), (unknown), Bo Hu, (unknown), Aki Imai‐Matsushima, Camille Locht, Eusondia Arnett, Larry S. Schlesinger, Thomas Zöller, Mariana Schürmann, Stefan H. E. Kaufmann, Hedda Wardemann	115
19	The Pore-Forming Toxin Listeriolysin O Mediates a Novel Entry Pathway of L. monocytogenes into Human Hepatocytes 2011 ·PLoS Pathogens ·Stephen Vadia, Eusondia Arnett, (unknown), (unknown), Rodney K. Tweten, Stéphanie Seveau	108
20	The Multifaceted Activities of Mammalian Defensins 2011 ·Current Pharmaceutical Design ·Eusondia Arnett, Stéphanie Seveau	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact